As SOX2 functions as a transcription factor in promoting the cancer stem cell phenotype, this suggests that the tumor-suppressing effects of TGF-β are associated with SOX2 inhibition of lncRNA H19 transcription in TICs (Zhang J. et al., 2019). Here, SOX2 is linked to neoplasm.